Oliver Sartor
Oliver Sartor
Email verificata su tulane.edu - Home page
Titolo
Citata da
Citata da
Anno
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
JS De Bono, S Oudard, M Ozguroglu, S Hansen, JP Machiels, I Kocak, ...
The Lancet 376 (9747), 1147-1154, 2010
32182010
Alpha emitter radium-223 and survival in metastatic prostate cancer
C Parker, S Nilsson, D Heinrich, SI Helle, JM O'sullivan, SD Fosså, ...
New England Journal of Medicine 369 (3), 213-223, 2013
26602013
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group
GJ Bubley, M Carducci, W Dahut, N Dawson, D Daliani, M Eisenberger, ...
Journal of Clinical Oncology 17 (11), 3461-3467, 1999
10891999
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
KR Carson, AM Evens, EA Richey, TM Habermann, D Focosi, JF Seymour, ...
Blood, The Journal of the American Society of Hematology 113 (20), 4834-4840, 2009
9292009
Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3
HI Scher, MJ Morris, WM Stadler, C Higano, E Basch, K Fizazi, ...
Journal of Clinical Oncology 34 (12), 1402, 2016
6732016
Prostate specific antigen best practice statement: 2009 update
KL Greene, PC Albertsen, RJ Babaian, HB Carter, PH Gann, M Han, ...
The Journal of urology 189 (1), S2-S11, 2013
5992013
Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...
European urology 73 (2), 178-211, 2018
498*2018
Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer.
CL Bennett, MR Ferreira, TC Davis, J Kaplan, M Weinberger, T Kuzel, ...
Journal of Clinical Oncology 16 (9), 3101-3104, 1998
4731998
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind …
O Sartor, R Coleman, S Nilsson, D Heinrich, SI Helle, JM O'Sullivan, ...
The Lancet Oncology 15 (7), 738-746, 2014
4362014
Radiation with or without antiandrogen therapy in recurrent prostate cancer
WU Shipley, W Seiferheld, HR Lukka, PP Major, NM Heney, DJ Grignon, ...
New England Journal of Medicine 376 (5), 417-428, 2017
4082017
Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline
IM Thompson, RK Valicenti, P Albertsen, BJ Davis, SL Goldenberg, ...
The Journal of urology 190 (2), 441-449, 2013
3802013
On the actions of the growth hormone-releasing hexapeptide, GHRP
CY Bowers, AO Sartor, GA Reynolds, TM Badger
Endocrinology 128 (4), 2027-2035, 1991
3771991
Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities
SE Eggener, PT Scardino, PR Carroll, MJ Zelefsky, O Sartor, H Hricak, ...
The Journal of urology 178 (6), 2260-2267, 2007
3732007
Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer
O Sartor, RH Reid, PJ Hoskin, DP Quick, PJ Ell, RE Coleman, JA Kotler, ...
Urology 63 (5), 940-945, 2004
3612004
Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a …
P Hoskin, O Sartor, JM O'Sullivan, DC Johannessen, SI Helle, J Logue, ...
The Lancet Oncology 15 (12), 1397-1406, 2014
3362014
Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior …
CN Sternberg, DP Petrylak, O Sartor, JA Witjes, T Demkow, JM Ferrero, ...
Journal of clinical oncology 27 (32), 5431, 2009
3342009
Olaparib for metastatic castration-resistant prostate cancer
J de Bono, J Mateo, K Fizazi, F Saad, N Shore, S Sandhu, KN Chi, ...
New England Journal of Medicine 382 (22), 2091-2102, 2020
3262020
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
S Gillessen, A Omlin, G Attard, JS De Bono, E Efstathiou, K Fizazi, ...
Annals of Oncology 26 (8), 1589-1604, 2015
3012015
Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP
YJ Bang, F Pirnia, WG Fang, WK Kang, O Sartor, L Whitesell, MJ Ha, ...
Proceedings of the National Academy of Sciences 91 (12), 5330-5334, 1994
2961994
Metastatic prostate cancer
O Sartor, JS de Bono
New England Journal of Medicine 378 (7), 645-657, 2018
2132018
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20